FDA goes nano

The Food & Drug Administration believes it has the authority to regular nanomaterials. The FDA faces a daunting task, however, in accruing the necessary resources and expertise. A conference held in Washington, D.C. by the nonprofit Food & Drug Law Institute heard that law, regulations, and policy are going to have to take a giant leap if they are to keep up with the pace of nanotechnology development, according to FDLI President James Kelly. "Nanoengineered materials may become part of any or all of the products that are regulated by the agency," said FDA's Norris Alderson. Public perception of nanotech safety will be key to commercial success, experts at the FDLI conference agreed that the FDA will play a crucial role in this acceptance.